$LH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LABORATORY CORP OF AMERICA HOLDINGS. Get notifications about new insider transactions in LABORATORY CORP OF AMERICA HOLDINGS for free.
Page: < prev 1 2 3 4 5 6 7 ... 37 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Schechter Adam H | President & CEO | Option Exercise | A | 182.51 | 45,600 | 8,322,456 | 45,600 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Schechter Adam H | President & CEO | Option Exercise | A | 0.00 | 10,520 | 0 | 17,767 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Seltz Judith C | Chief Human Resourc ... | Option Exercise | A | 182.51 | 3,600 | 657,036 | 3,600 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Seltz Judith C | Chief Human Resourc ... | Option Exercise | A | 0.00 | 840 | 0 | 840 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Option Exercise | A | 182.51 | 3,600 | 657,036 | 3,600 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Option Exercise | A | 0.00 | 840 | 0 | 2,637 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | A | 182.51 | 7,300 | 1,332,323 | 7,300 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | A | 0.00 | 1,680 | 0 | 11,534 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | A | 182.51 | 7,300 | 1,332,323 | 7,300 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | A | 0.00 | 1,680 | 0 | 9,324 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 182.51 | 12,600 | 2,299,626 | 12,600 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 0.00 | 2,910 | 0 | 38,364 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Caveney Brian J | EVP, President of D ... | Option Exercise | A | 182.51 | 7,300 | 1,332,323 | 7,300 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Caveney Brian J | EVP, President of D ... | Option Exercise | A | 0.00 | 1,680 | 0 | 17,057 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | A | 182.51 | 1,900 | 346,769 | 1,900 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | Wilkinson Peter J | SVP, Chief Accounti ... | Option Exercise | A | 0.00 | 450 | 0 | 3,050 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 182.51 | 4,900 | 894,299 | 4,900 | |
| Feb 06 2020 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 1,120 | 0 | 10,004 | |
| Jan 03 2020 | LH | LABORATORY CORP OF ... | KING DAVID P | Director | Option Exercise | A | 0.00 | 38,570 | 0 | 62,527 | |
| Dec 06 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 0.00 | 3,271 | 0 | 1,227 | |
| Dec 06 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Payment of Exercise | F | 171.82 | 327 | 56,185 | 36,957 | 37.3 K to 37 K (-0.88 %) |
| Dec 06 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 0.00 | 3,271 | 0 | 37,284 | 34 K to 37.3 K (+9.62 %) |
| Dec 04 2019 | LH | LABORATORY CORP OF ... | Davis Jeffrey A. | Director | Option Exercise | A | 0.00 | 173 | 0 | 173 | |
| Nov 07 2019 | LH | LABORATORY CORP OF ... | Caveney Brian J | EVP, President of D ... | Option Exercise | A | 0.00 | 6,030 | 0 | 15,377 | |
| Nov 07 2019 | LH | LABORATORY CORP OF ... | Schroeder Mark S | EVP, President-Diag ... | Option Exercise | A | 0.00 | 6,030 | 0 | 7,644 | |
| Nov 05 2019 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | A | 0.00 | 6,020 | 0 | 9,854 | |
| Nov 05 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 0.00 | 30,080 | 0 | 35,454 | |
| Nov 05 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | President & CEO | Option Exercise | A | 191.51 | 65,100 | 12,467,301 | 65,100 | |
| Nov 05 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | President & CEO | Option Exercise | A | 166.53 | 24,800 | 4,129,944 | 24,800 | |
| Nov 05 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | President & CEO | Option Exercise | A | 0.00 | 6,020 | 0 | 7,247 | |
| Oct 30 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 166.21 | 12,352 | 2,053,053 | 305,933 | 318.3 K to 305.9 K (-3.88 %) |
| Oct 30 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 165.32 | 10,391 | 1,717,832 | 318,285 | 328.7 K to 318.3 K (-3.16 %) |
| Oct 30 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 164.16 | 7,434 | 1,220,332 | 328,676 | 336.1 K to 328.7 K (-2.21 %) |
| Sep 25 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 98.49 | 2,600 | 256,074 | 0 | |
| Sep 25 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Sell | S | 171.85 | 2,600 | 446,810 | 17,933 | 20.5 K to 17.9 K (-12.66 %) |
| Sep 25 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 98.49 | 2,600 | 256,074 | 20,533 | 17.9 K to 20.5 K (+14.50 %) |
| Sep 06 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 130.60 | 2,466 | 322,060 | 1,234 | |
| Sep 06 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Sell | S | 168.59 | 2,466 | 415,743 | 4,660 | 7.1 K to 4.7 K (-34.61 %) |
| Sep 06 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 130.60 | 2,466 | 322,060 | 7,126 | 4.7 K to 7.1 K (+52.92 %) |
| Sep 04 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Sell | S | 169.80 | 5,902 | 1,002,172 | 6,097 | 12 K to 6.1 K (-49.19 %) |
| Aug 07 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 162.91 | 500 | 81,455 | 6,886 | 7.4 K to 6.9 K (-6.77 %) |
| Aug 07 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 162.91 | 500 | 81,455 | 6,886 | 7.4 K to 6.9 K (-6.77 %) |
| Jul 10 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 176.75 | 5,563 | 983,260 | 17,059 | 22.6 K to 17.1 K (-24.59 %) |
| Jul 10 2019 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Sell | S | 176.75 | 2,328 | 411,474 | 2,328 | 4.7 K to 2.3 K (-50.00 %) |
| Jun 21 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 77.19 | 3,100 | 239,289 | 0 | |
| Jun 21 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Sell | S | 170.00 | 3,100 | 527,000 | 19,133 | 22.2 K to 19.1 K (-13.94 %) |
| Jun 21 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 77.19 | 3,100 | 239,289 | 22,233 | 19.1 K to 22.2 K (+16.20 %) |
| Jun 11 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 168.41 | 1,294 | 217,921 | 22,622 | 23.9 K to 22.6 K (-5.41 %) |
| Jun 11 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 167.65 | 4,450 | 746,045 | 23,916 | 28.4 K to 23.9 K (-15.69 %) |
| Jun 11 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 166.82 | 4,256 | 710,003 | 28,366 | 32.6 K to 28.4 K (-13.05 %) |
| May 13 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 306 | 0 | 0 | |
| May 13 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 306 | 0 | 15,515 | 15.2 K to 15.5 K (+2.01 %) |
| May 08 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 162.20 | 500 | 81,100 | 7,386 | 7.9 K to 7.4 K (-6.34 %) |
| May 07 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 64.42 | 3,700 | 238,354 | 0 | |
| May 07 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 166.30 | 3,700 | 615,310 | 15,209 | 18.9 K to 15.2 K (-19.57 %) |
| May 07 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 64.42 | 3,700 | 238,354 | 18,909 | 15.2 K to 18.9 K (+24.33 %) |
| May 06 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Sell | S | 164.00 | 4,000 | 656,000 | 4,638 | 8.6 K to 4.6 K (-46.31 %) |
| May 06 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Sell | S | 164.00 | 4,000 | 656,000 | 4,638 | 8.6 K to 4.6 K (-46.31 %) |
| Apr 05 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 2,424 | 0 | 19,787 | |
| Apr 05 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 156.68 | 1,084 | 169,841 | 16,941 | 18 K to 16.9 K (-6.01 %) |
| Apr 05 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 2,424 | 0 | 18,025 | 15.6 K to 18 K (+15.54 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 154.79 | 41,311 | 6,394,530 | 297,387 | 338.7 K to 297.4 K (-12.20 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 92,417 | 0 | 338,698 | 246.3 K to 338.7 K (+37.53 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 154.79 | 10,013 | 1,549,912 | 32,622 | 42.6 K to 32.6 K (-23.49 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Grant | A | 0.00 | 22,400 | 0 | 42,635 | 20.2 K to 42.6 K (+110.70 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Payment of Exercise | F | 154.79 | 1,782 | 275,836 | 4,656 | 6.4 K to 4.7 K (-27.68 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | van der Vaart Sandra D | SVP, Global General ... | Grant | A | 0.00 | 5,530 | 0 | 6,438 | 908 to 6.4 K (+609.03 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 154.79 | 1,779 | 275,371 | 13,663 | 15.4 K to 13.7 K (-11.52 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Grant | A | 0.00 | 5,530 | 0 | 15,442 | 9.9 K to 15.4 K (+55.79 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 154.79 | 3,236 | 500,900 | 8,638 | 11.9 K to 8.6 K (-27.25 %) |
| Apr 03 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Grant | A | 0.00 | 7,385 | 0 | 11,874 | 4.5 K to 11.9 K (+164.51 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 4,506 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 3,279 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | M | 64.42 | 3,700 | 238,354 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Payment of Exercise | F | 146.59 | 104 | 15,245 | 34,013 | 34.1 K to 34 K (-0.30 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 0.00 | 1,038 | 0 | 34,117 | 33.1 K to 34.1 K (+3.14 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Sell | S | 146.06 | 3,700 | 540,407 | 33,079 | 36.8 K to 33.1 K (-10.06 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Buy | M | 64.42 | 3,700 | 238,354 | 36,779 | 33.1 K to 36.8 K (+11.19 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 146.59 | 52,300 | 7,666,657 | 52,300 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 12,710 | 0 | 23,957 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 3,513 | 0 | 11,247 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 146.59 | 1,571 | 230,293 | 246,281 | 247.9 K to 246.3 K (-0.63 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 3,513 | 0 | 247,852 | 244.3 K to 247.9 K (+1.44 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Buy | M | 0.00 | 1,038 | 0 | 8,769 | 7.7 K to 8.8 K (+13.43 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 0.00 | 1,038 | 0 | 19,133 | 18.1 K to 19.1 K (+5.74 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Buy | M | 0.00 | 1,038 | 0 | 7,225 | 6.2 K to 7.2 K (+16.78 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Buy | M | 0.00 | 1,038 | 0 | 3,861 | 2.8 K to 3.9 K (+36.77 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 306 | 0 | 306 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,038 | 0 | 15,209 | 14.2 K to 15.2 K (+7.32 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Buy | M | 0.00 | 1,038 | 0 | 6,462 | 5.4 K to 6.5 K (+19.14 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Gift | G | 0.00 | 610 | 0 | 5,424 | 6 K to 5.4 K (-10.11 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 1,227 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 147.00 | 1,038 | 152,586 | 7,886 | 8.9 K to 7.9 K (-11.63 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Buy | M | 0.00 | 1,038 | 0 | 8,924 | 7.9 K to 8.9 K (+13.16 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 233 | 0 | 764 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 146.59 | 64 | 9,382 | 28,823 | 28.9 K to 28.8 K (-0.22 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 233 | 0 | 28,887 | 28.7 K to 28.9 K (+0.81 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 146.59 | 3,800 | 557,042 | 3,800 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 0.00 | 930 | 0 | 1,771 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 256 | 0 | 841 | |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 146.59 | 103 | 15,099 | 4,489 | 4.6 K to 4.5 K (-2.24 %) |
| Feb 14 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 256 | 0 | 4,592 | 4.3 K to 4.6 K (+5.90 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,047 | 0 | 3,334 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,830 | 0 | 6,381 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 144.29 | 905 | 130,582 | 19,687 | 20.6 K to 19.7 K (-4.39 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 3,047 | 0 | 20,592 | 17.5 K to 20.6 K (+17.37 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 144.29 | 544 | 78,494 | 17,545 | 18.1 K to 17.5 K (-3.01 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,830 | 0 | 18,089 | 16.3 K to 18.1 K (+11.26 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 3,047 | 0 | 997 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 450 | 0 | 4,044 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 144.29 | 905 | 130,582 | 8,593 | 9.5 K to 8.6 K (-9.53 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 3,047 | 0 | 9,498 | 6.5 K to 9.5 K (+47.23 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 144.29 | 132 | 19,046 | 6,451 | 6.6 K to 6.5 K (-2.01 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 450 | 0 | 6,583 | 6.1 K to 6.6 K (+7.34 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 604 | 0 | 1,097 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 144.29 | 240 | 34,630 | 4,336 | 4.6 K to 4.3 K (-5.24 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 604 | 0 | 4,576 | 4 K to 4.6 K (+15.21 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 450 | 0 | 837 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 144.29 | 124 | 17,892 | 9,770 | 9.9 K to 9.8 K (-1.25 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 450 | 0 | 9,894 | 9.4 K to 9.9 K (+4.76 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 7,544 | 0 | 14,760 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 144.29 | 2,980 | 429,984 | 244,339 | 247.3 K to 244.3 K (-1.20 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 7,544 | 0 | 247,319 | 239.8 K to 247.3 K (+3.15 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 520 | 0 | 997 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 144.29 | 143 | 20,633 | 28,654 | 28.8 K to 28.7 K (-0.50 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 520 | 0 | 28,797 | 28.3 K to 28.8 K (+1.84 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 6,100 | 0 | 18,374 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 144.29 | 1,973 | 284,684 | 14,792 | 16.8 K to 14.8 K (-11.77 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 6,100 | 0 | 16,765 | 10.7 K to 16.8 K (+57.20 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 1,863 | 0 | 24,474 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 147.46 | 556 | 81,988 | 10,665 | 11.2 K to 10.7 K (-4.95 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 1,863 | 0 | 11,261 | 9.4 K to 11.3 K (+19.82 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 4,220 | 0 | 22,304 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 147.46 | 1,254 | 184,915 | 239,775 | 241 K to 239.8 K (-0.52 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 4,220 | 0 | 241,029 | 236.8 K to 241 K (+1.78 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 993 | 0 | 8,211 | |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 147.46 | 297 | 43,796 | 16,259 | 16.6 K to 16.3 K (-1.79 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 993 | 0 | 16,556 | 15.6 K to 16.6 K (+6.38 %) |